Brought to you by:
PAD: Endologix acquires PQ Bypass
Endologix recently announced completing the acquisition of PQ Bypass, a medical technology company pioneering a first-of-its-kind technology that addresses severe peripheral arterial disease (PAD). PQ Bypass’ proprietary Detour platform for percutaneous femoropopliteal bypass has been designated by the Food and…
Endologix enters into agreement with Deerfield Partners to take company private
Endologix has announced that, after evaluating a variety of strategic options, it has initiated a voluntary Chapter 11 case and simultaneously filed a consensual plan of reorganization supported by Deerfield Partners as its largest creditor. According to a press release,…